Last update 08 May 2025

Yangxin Shengmai Granules

Overview

Basic Info

Drug Type
Herbal medicine
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Nervous System Diseases
Active Indication
Chest Pain
Inactive Indication-
Originator Organization
Qinhuangdao Shanhaiguan Pharmaceutical Co. Ltd.Qinhuangdao Shanhaiguan Pharmaceutical Co. Ltd.
Active Organization
Qinhuangdao Shanhaiguan Pharmaceutical Co. Ltd.Qinhuangdao Shanhaiguan Pharmaceutical Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
China (07 Apr 2020),
Chest Pain
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with Yangxin Shengmai Granules
ChiCTR2400084236
/ RecruitingPhase 4IIT
The randomized, double-blind, parallel-controlled, multi-center clinical trial on the effectiveness and safety of Yangxin Shengmai Granules in the treatment of stable angina pectoris of coronary heart disease (Qi-Yin deficiency syndrome) under the protection of traditional Chinese medicine (TCM) varieties
NCT04270071
/ Unknown statusPhase 4IIT
Efficacy and Safety of Yangxin Shengmai Granules for the Treatment of Stable Angina Pectoris: Randomised, Double Blind, Placebo Controlled Trial
ChiCTR2400088123
/ CompletedPhase 4IIT
A multicenter, randomized, double-blind, placebo parallel controlled study to evaluate the efficacy and safety of Yangxin Shengmai Granules in the treatment of stable angina pectoris in patients with coronary heart disease
100 Clinical Results associated with Yangxin Shengmai Granules
Login to view more data
100 Translational Medicine associated with Yangxin Shengmai Granules
Login to view more data
100 Patents (Medical) associated with Yangxin Shengmai Granules
Login to view more data
100 Deals associated with Yangxin Shengmai Granules
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Chest Pain
China
Qinhuangdao Shanhaiguan Pharmaceutical Co. Ltd.Qinhuangdao Shanhaiguan Pharmaceutical Co. Ltd.
07 Apr 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free